No. 22-120
Suntree Pharmacy, et al. v. Drug Enforcement Administration
Response Waived
Experienced Counsel
Tags: administrative-deference administrative-law controlled-substances dea dea-registration deference legitimate-medical-purpose medical-purpose prescription prescription-filling regulatory-interpretation
Key Terms:
DueProcess Patent JusticiabilityDoctri
DueProcess Patent JusticiabilityDoctri
Latest Conference:
2022-10-07
Question Presented (from Petition)
Whether a pharmacy violates its corresponding responsibility under 21 C.F.R. § 1306.04(a) and knowingly fills a prescription for a controlled substance not issued for a legitimate medical purpose where the prescription's legitimacy remains undetermined?
Question Presented (AI Summary)
Whether a pharmacy violates its corresponding responsibility under 21 C.F.R. § 1306.04(a) and knowingly fills a prescription for a controlled substance not issued for a legitimate medical purpose where the prescription's legitimacy remains undetermined?
Docket Entries
2022-10-11
Petition DENIED.
2022-09-21
DISTRIBUTED for Conference of 10/7/2022.
2022-09-16
Waiver of right of respondent Drug Enforcement Administration to respond filed.
2022-08-03
Petition for a writ of certiorari filed. (Response due September 8, 2022)
Attorneys
Drug Enforcement Administration
Elizabeth B. Prelogar — Solicitor General, Respondent
Suntree Pharmacy, et al.
Ronald William Chapman II — Chapman Law Group, Petitioner